ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2025
Unique Presentation of Postpartum Hypereosinophilic Syndrome With Atypical Features and Therapeutic Challenges.
Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypereosinophilic syndrome (HES) is an assemblage of disorders leading to marked eosinophilic tissue infiltration resulting in organ dysfunction. This case report describes a challenging diagnosis of HES identified in the postpartum period, a rare presentation of this disease process. Case Presentation: A 32-year-old active-duty service member with allergic rhinitis and childhood eczema developed a progressive pruritic rash and severe, recurrent epigastric pain with vomiting and weight loss 3 months following the birth of her first child. The patient gradually developed intermittent facial swelling, night sweats, and dyspnea, resulting in hospitalization. Two absolute eosinophil counts (AECs) taken more than a month apart ranged from 1600 to 4787 cells/μL. Mature eosinophils were found on skin, bone marrow, and duodenal biopsies. Radiography revealed no detectable neoplasm, and there was no clinical evidence of cardiac involvement. Testing revealed no mutations indicative of familial, myeloproliferative, or lymphocytic variants. The patient was started on empiric treatment with symptom improvement, which was gradually discontinued due to a second pregnancy. Conclusions: The patient described in this case met diagnostic criteria for HES; however, the complicated clinical and laboratory features made it challenging to characterize her disease as a specific HES variant, rendering it difficult to determine the optimal treatment regimen. Further therapy was complicated by a new pregnancy. It is important for clinicians to recognize an abnormally elevated AEC, promptly initiate systematic evaluation, and minimize delays in diagnosis and treatment of potential HES in order to avoid the extensive morbidity and mortality that can be associated with HES.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.